Latest Stock Market News

After a dismal start to the year for stocks that saw the S&P 500 fall into a correction, commonly referred to as a drop of more than 10% from its most recent high, the benchmark index is now down less than 3% on the year.

The orders came after Sebi observed large scale reversal trades in the stock options segment on BSE, leading to creation of artificial volumes in the segment.

The deal happened at an average price of Rs 95 per unit, taking the transaction size to Rs 19 crore. It was not clear who bought these shares.

The Dow Jones Industrial Average fell 20.6 points, or 0.06%, at the open to 35,273.63.

​​ Issuing a circular, the watchdog said the rebalancing period will be applicable in the event of deviation from mandated asset allocation mentioned in the Scheme Information Document (SID) due to passive breaches.

Market will not only have the weekly options expiry on Thursday, but also has monthly derivative expiry. The session will stay highly influenced by the rollover-centric activities.

Axis will pay to Citi cash consideration of approximately $1.6 billion for the acquisition of the consumer business, subject to customary closing adjustments. The transaction comprises the sale of the consumer banking businesses of Citibank India, which includes credit cards, retail banking, wealth management and consumer loans.

“The sentiments will be positive given the value of the deals and it should be taken positively because if the cash outgo was greater, then it could have been taken negatively. Near term performance after the initial popup would depend on how the overall market plays out. So there is a possibility of an initial pop up, but after that it will be more market dependent.”

However, the FPI holding value is massively down from the record $667 billion in the first half of FY22, which was an addition of a full $112 billion between April 1 and September 30, 2021, according to a previous BofA report.

Nifty Pharma closed lower, bucking the overall trend. Aurobindo Pharma fell 2 per cent while Glenmark Pharma declined about half a per cent. Ipca and Dr Reddy’s Labs , however, ended in the green.